Recombinant chimeric monoclonal antibody to CD19 for use as a research grade Obexelimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Dose-response for Obexelimab Biosimilar - Anti-CD19 Antibody - BSA and Azide free (A338500).
Publishing research using Obexelimab Biosimilar - Anti-CD19 Antibody - BSA and Azide free (A338500)? Please let us know so that we can list the citation on this page.
Alternative products to Obexelimab Biosimilar - Anti-CD19 Antibody - BSA and Azide free (A338500)
Recombinant humanized monoclonal antibody to CD19 for use as a research grade Inebilizumab biosimila for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to CD19 for use as a research grade Tafasitamab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to CD19 for use as a research grade MDX-1342 biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to CD19 for use as a research grade Inebilizumab biosimila for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to CD19 for use as a research grade Tafasitamab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to CD19 for use as a research grade MDX-1342 biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.